三维支架取栓器联合抽吸取栓与单纯抽吸治疗急性缺血性卒中的随机临床试验
这项随机非劣效性试验在25个北美中心纳入198例大血管闭塞急性缺血性卒中患者,比较三维支架取栓器联合抽吸装置与单纯抽吸的疗效与安全性。主要终点mTICI 2-3再通率分别为87.2%与82.3%,差异4.9%(90%CI -3.6%至13.5%),符合非劣效性;器械与操作相关严重不良事件及90天功能预后两组无显著差异。
要点
- 三维支架取栓器联合抽吸的再通率非劣于单纯抽吸,差异4.9%(90%CI -3.6%至13.5%)。
- 器械相关严重不良事件发生率两组相近(4.1% vs 5.0%)。
- 90天mRS 0-2比例两组无显著差异(45.3% vs 45.8%)。
核心结论
- 三维支架取栓器联合抽吸在急性缺血性卒中治疗中非劣于单纯抽吸,提供1级证据。
- 未来试验需评估结果能否推广至其他支架取栓器。
研究设计与样本
- 随机、非劣效性临床试验,2012年5月19日至2015年11月19日在25个北美中心纳入患者,随访90天。
- 共筛查8082例,随机198例(三维支架取栓器联合抽吸组98例,单纯抽吸组100例),主要分析基于意向治疗人群。
- 入组标准为大血管颅内闭塞急性缺血性卒中,NIHSS评分≥8且发病8小时内。
主要发现
- 主要疗效终点mTICI 2-3再通率:联合组87.2%(82/94),单纯抽吸组82.3%(79/96),差异4.9%(90%CI -3.6%至13.5%)。
- 器械相关严重不良事件:联合组4.1%(4/98),单纯抽吸组5.0%(5/100)。
- 操作相关严重不良事件:联合组10.2%(10/98),单纯抽吸组14.0%(14/100)。
- 90天mRS 0-2:联合组45.3%(39/86),单纯抽吸组45.8%(44/96)。
- 其他指标两组间无显著差异。
关键数值与推荐
- 非劣效性界值为15%,主要终点mTICI 2-3率差异4.9%(90%CI -3.6%至13.5%),未超过界值。
- 基线NIHSS中位数18.0(四分位距14.0-23.0)。
临床怎么用
- 对于大血管闭塞急性缺血性卒中,三维支架取栓器联合抽吸可作为单纯抽吸的替代选择。
- 临床决策时需结合器械可及性和操作者经验。
局限性
- 结果可能仅限于所研究的特定三维支架取栓器,不能直接推广至其他支架取栓器。
- 试验纳入患者数有限(198例),可能影响对罕见不良事件的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The treatment effects of individual mechanical thrombectomy devices in large-vessel acute ischemic stroke (AIS) remain unclear. OBJECTIVE: To determine whether the novel 3-dimensional (3-D) stent retriever used in conjunction with an aspiration-based mechanical thrombectomy device (Penumbra System; Penumbra) is noninferior to aspiration-based thrombectomy alone in AIS. DESIGN, SETTING, AND PARTICIPANTS: This randomized, noninferiority clinical trial enrolled patients at 25 North American centers from May 19, 2012, through November 19, 2015, with follow-up for 90 days. Adjudicators of the primary end points were masked to treatment allocation. Patients with large-vessel intracranial occlusion AIS presenting with a National Institutes of Health Stroke Scale (NIHSS) score of at least 8 within 8 hours of onset underwent 1:1 randomization to 3-D stent retriever with aspiration or aspiration alone. The primary analyses were conducted in the intention-to-treat population. INTERVENTIONS: Mechanical thrombectomy using intracranial aspiration with or without the 3-D stent retriever. MAIN OUTCOMES AND MEASURES: The primary effectiveness end point was the rate of a modified Thrombolysis in Cerebral Infarction (mTICI) grade of 2 to 3 with a 15% noninferiority margin. Device- and procedure-related serious adverse events at 24 hours were the primary safety end points. RESULTS: Of 8082 patients screened, 198 patients were enrolled (111 women [56.1%] and 87 men [43.9%]; mean [SD] age, 66.9 [13.0] years) and randomized, including 98 in the 3-D stent retriever with aspiration group and 100 in the aspiration alone group; an additional 238 patients were eligible but not enrolled. The median baseline NIHSS score was 18.0 (interquartile range, 14.0-23.0). Eighty-two of 94 patients in the 3-D stent retriever and aspiration group (87.2%) had an mTICI grade of 2 to 3 compared with 79 of 96 in the aspiration alone group (82.3%; difference, 4.9%; 90% CI, -3.6% to 13.5%). None of the other measures were significantly different between the 2 groups. Device-related serious adverse events were reported by 4 of 98 patients in the 3-D stent retriever with aspiration group (4.1%) vs 5 of 100 patients in the aspiration only group (5.0%); procedure-related serious adverse events, 10 of 98 (10.2%) vs 14 of 100 (14.0%). A 90-day modified Rankin Scale score of 0 to 2 was reported by 39 of 86 patients in the 3-D stent retriever with aspiration group (45.3%) vs 44 of 96 patients in the aspiration only group (45.8%). CONCLUSIONS AND RELEVANCE: The present study provides class 1 evidence for the noninferiority of the 3-D stent retriever with aspiration vs aspiration alone in AIS. Future trials should evaluate whether these results can be generalized to other stent retrievers. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01584609.
引用
- Nogueira RG, Frei D, Kirmani JF, et al. Safety and Efficacy of a 3-Dimensional Stent Retriever With Aspiration-Based Thrombectomy vs Aspiration-Based Thrombectomy Alone in Acute Ischemic Stroke Intervention: A Randomized Clinical Trial. JAMA Neurol. 2018. PMID: 29296999. doi:10.1001/jamaneurol.2017.3967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。